Introduction: Hypercalcemia, characterized by elevated levels of calcium in the blood, is a metabolic disorder associated with various underlying etiologies, including primary hyperparathyroidism, malignancy, vitamin D toxicity, and certain medications. It presents a clinical challenge due to its diverse manifestations and potential complications, such as renal impairment, cardiovascular events, and skeletal abnormalities. The hypercalcemia market […]


